Most suitable funds for any long-term growth portfolio...
Funds for regular income seekers to derive dependable, inflation-protected income...
Funds that combine wealth creation with tax saving under Section 80C...
The largest, most consistently profitable and prestigious companies available at a bargain.
Stock available below their intrinsic value based on principles set by the father of value investing.
Stocks trading near their 52-week price.
Drugs & Pharma
Join now and be among the first to discover Stock Ideas
Sigachi Industries IPO: Information analysis
IPO update: Windlas Biotech
Windlas Biotech: IPO analysis
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Compliances-Reg.24(A)-Annual Secretarial Compliance
more stories >